Davis has 19 years of experience in sales, marketing, and business development with both early stage and Fortune 500 medical device, technology and consumer product companies, with much of his experience focused on bringing neurovascular innovations to market. He joins Imperative Care from Penumbra, where he launched the first U.S. Food and Drug Administration-cleared aspiration system for neurovascular mechanical thrombectomy and served as chief commercial officer and president of North America.
“I am thrilled to welcome an executive of Daniel’s high caliber and unique background to our executive leadership team,” said Fred Khosravi, Imperative Care’s founding chairman and CEO. “Imperative Care is charting a unique course by introducing innovative technologies that address the continuum of stroke care. Daniel’s pioneering contributions to the neurovascular space will add immense value as we move into the next stage of growth for our company.”
“Like millions of families affected by stroke each year, I have seen firsthand the critical role that fast and effective treatment plays in patient survival and optimal recovery,” said Davis. “Imperative Care’s commitment to innovation, broad focus on addressing unmet needs, as well as its rigorous focus on clinical evidence, have laid a strong foundation for the company to become a clear leader in revolutionizing this space. I am honored to join a leadership team that is devoted to elevating the treatment of stroke and making innovative technologies more widely available to patients.”
Imperative Care is poised to commercialize the industry’s first Large Distal Platform (LDP) access technology and an unparalleled ZOOM Aspiration System in the U.S. market, and is also developing a pipeline of additional stroke-care innovations.
Stroke remains a largely unaddressed problem that affects over 800,000 Americans each year. The number of deaths due to stroke continues to rise, and a recent study published in The New England Journal of Medicine estimates that the global risk of stroke from the age of 25 years onward is approximately 25 percent among both men and women. Treatment options have significantly improved over the last decade, but the need for improved effectiveness and efficiency remains. Imperative Care aims to invest significantly in clinical evidence to advance the standard of care for stroke patients worldwide.
Based in Campbell, Calif., Imperative Care is speeding new answers to stroke by developing a portfolio of innovative solutions to address the vast and urgent unmet needs in stroke care. The company is singularly dedicated to improving the way stroke is treated by advancing medical technology, equipping healthcare providers to evolve best practices and elevate the standard of care for stroke patients.